Fitgenes is pleased to offer a short course for degree qualified and interested health and allied professionals wishing to build upon their understanding of the current research on the AMY1 gene's relationship with weight management, diet and fitness.
See the CarbChoice program as a great way to get started with Fitgenes.
How well do your clients process carbohydrates?
Is poor processing the cause of ongoing health issues?
Offer your clients support for managing how their body processes starchy carbohydrates. Learn the value of testing the AMY1 gene variation and interpret the genetic profile report for clinical application in managing carbohydrate metabolism.
Fitgenes Australia is a world leader in developing a genetic profile reports and supporting practitioners with clinical interventions that address the role of the AMY1 gene CNV in starch metabolism.
Scientific studies have shown that variations in the human salivary amylase gene (AMY1) differ based on populations, which have traditionally eaten high starch diets, compared to those who have traditionally eaten low starch diets. Copy number variations within the AMY1 gene impact salivary amylase activity (Yang et al., 2015; Santos et al. 2012), which influences how well the body breaks down and processes starch. Simply, some people can process starchy carbohydrates better than others.
Amylase activity, and the ability to process starch, has been demonstrated to have impact on BMI (Bonnefond, 2017) and hence AMY1 copy number can impact on the related issues of BMI, obesity and weight management. (Falchi et al., 2014; Mejía-Benítez, 2015; Viljakainen, 2015; Marcovecchio 2016).
Our eLearning course is designed to educate practitioners on how to test their patients' AMY1 gene copy number variation and interpret the profile report for clinical application.
Our unique profile report:
Enrol in our online training course and help guide your patients towards better health and wellbeing.